What changed at CPC in July, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The Supply Chain Dispatch
Norway health authority warns on falsified semaglutide pens
Reported from the analysis, not from a warning notice.
The health authority in Norway has issued a warning on falsified semaglutide injection pens found in the legitimate supply chain. The Journal has reviewed the notice and the accompanying photographs; the distinguishing features are a batch-number font difference and a needle-shield colour, neither of which a patient could reasonably be expected to detect.
Comparison of 20 certificates supplied by the reseller against the laboratory’s public archive matched 10 of them to reports commissioned by other parties, in some cases more than a year earlier. The reseller did not respond to two written requests for comment.
The document is the weakest link in this trade. A certificate is a PDF; a laboratory letterhead is an image; a lot number is a string. Nothing in the ordinary transaction allows a buyer to confirm that a given report was issued for a given vial, and the four independent services differ in whether they offer any lookup at all.
Yusuf Kandemir, freight and customs broker, Istanbul, said the underfill finding was the more consequential one. "Nobody is being poisoned by a low content figure. Everybody using that vial is out by a fifth in every calculation they make."
The Journal has referred the cloned document to the laboratory named on it and has asked all four independent services whether they will offer a public report-number lookup. Two have replied.
Related coverage
Janoshik result on a Suzhou tirzepatide lot lands 4.1 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
Nigeria health authority warns on falsified dulaglutide pens
Reported from the analysis, not from a warning notice.
A tested vial is evidence about a vial
A result on one vial generalises to a batch only if the vial was drawn in a way that makes it representative — and nobody records how it was drawn.
JEEP declines, for the 21st time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The pyrogen question has a price, and it is not the price of a purity run
The absence of microbiological capability in this market is a commercial fact with a straightforward explanation, and it is worth understanding before blaming anybody for it.